Overview
Karthikeyan Mahalingam practices in New Delhi, India. Mr. Mahalingam is rated as a Distinguished expert by MediFind in the treatment of Glaucoma. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.
His clinical research consists of co-authoring 75 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 39 articles in the study of Glaucoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GlaucomaMr. Mahalingam isDistinguished. Learn about Glaucoma.
- Ocular Hypertension (OHT)Mr. Mahalingam isDistinguished. Learn about Ocular Hypertension (OHT).
- TrabeculectomyMr. Mahalingam isDistinguished. Learn about Trabeculectomy.
- Advanced
- ColobomaMr. Mahalingam isAdvanced. Learn about Coloboma.
- Pigment-Dispersion SyndromeMr. Mahalingam isAdvanced. Learn about Pigment-Dispersion Syndrome.
- Experienced
- AniridiaMr. Mahalingam isExperienced. Learn about Aniridia.
- Brown SyndromeMr. Mahalingam isExperienced. Learn about Brown Syndrome.
- BullaeMr. Mahalingam isExperienced. Learn about Bullae.
- Cataract RemovalMr. Mahalingam isExperienced. Learn about Cataract Removal.
- Congenital CataractMr. Mahalingam isExperienced. Learn about Congenital Cataract.
- COVID-19Mr. Mahalingam isExperienced. Learn about COVID-19.